Legend Biotech
J&J-backed Cell Therapies Developer Legend Biotech Files For Nasdaq IPO
Business - Published date: .
Legend Biotech, a global novel cell therapy spin-off of Hong Kong-listed biotech company GenScript Biotech, has filed f... Read more